Insurance claim topic
Guides, regulatory updates, judgments and practical reporting on health insurance claims in India.
Topic collection
Cashless treatment, reimbursement, hospitalisation, IRDAI rules and health-claim disputes.
The Ghaziabad consumer commission directed Star Health to reimburse Rs 61,582 to a policyholder, ruling that the burden of proving pre-existing illness lies with the insurer and mere suspicion is not enough to reject a claim.
The Hansa Research CuES 2026 report reveals that while health insurance adoption in India is rising, customer experience is declining. Claims friction, network issues, and transparency gaps remain key pain points.
Tamil Nadu Chief Minister C. Joseph Vijay announced on 19 August 2026 that CMCHIS annual cover would increase from Rs 5 lakh to Rs 25 lakh per family. The announcement is clear, but beneficiaries should verify the effective date, government order and package-level implementation before assuming the higher limit is already usable.
Health insurance claims can be rejected, disallowed or reduced for different reasons. Careful disclosure, understanding medical necessity and checking policy conditions can reduce avoidable disputes, but no single statistic should be treated as a universal rejection rate.
Health insurance claims in India face systemic challenges: 11-12.9% rejection rates, cashless delays stretching to 48 hours, documentation gaps, and lack of transparency. Here is a comprehensive guide to the common issues, your IRDAI rights, and how to fight back.
ICICI Lombard denied cashless treatment for a hip replacement and cancelled a 7-year-old health policy, alleging non-disclosure of a 2005 surgery. The Telangana State Consumer Commission ruled the termination illegal and ordered Rs 2.57 lakh payout, calling it unfair trade practice.
Reuters reported that an IRDAI-chaired panel is weighing benchmark treatment rates, a common health insurance product, a uniform treatment list and wider NHCX adoption to address medical inflation, claims friction and fraud. The proposals are still under consideration.
A LocalCircles survey found that 44% of claim-outcome respondents said their health claim was rejected or partially approved for reasons they considered invalid. Half of discharge-time respondents reported a 6-48 hour process, while IRDAI's current cashless timelines are 1 hour for pre-authorisation and 3 hours for final discharge authorisation.
The National Health Authority's AB PM-JAY Auto-Adjudication Hackathon 2026 invited AI solutions to reduce manual work, improve speed and strengthen fraud detection across roughly 40,000–50,000 daily claims and 1,900+ treatment packages. NHA said 15–20% of claims were already auto-adjudicated in April 2026.
A Delhi consumer commission has ordered Manipal Cigna to pay Rs 2.33 lakh after it repeatedly rejected a brain tumour surgery claim on shifting grounds — first alleging non-disclosure, then claiming missing documents. The commission called it 'deficiency in service' and warned insurers against changing rejection reasons to avoid payout.
Your cashless claim was approved at admission, so why is the insurer denying it at discharge? Here is the critical difference between provisional approval and final settlement that every hospitalised patient must understand.
Industry data reveals that while 89 percent of health insurance claims were settled by policy, only 78 percent of the total claim amount was paid. Here is why the numbers you trust may be misleading you.
The General Insurance Council issued advisory clinical criteria for fever and infectious-disease admissions. The Council says the guidance is non-binding and does not replace clinical judgment, while some doctors fear insurers could use it to question cashless approvals or claims.
In Anilkumar B S v. State Medical Officer, the Kerala High Court held that this MEDISEP claim could not be rejected solely because treatment was taken at a non-empanelled hospital where suitable empanelled facilities were unavailable. The ruling is scheme- and fact-specific, not a blanket rule for every private health policy.
The Ropar District Consumer Commission directed Future Generali to reimburse Rs 90,079 for a son's dengue treatment after finding that alleged discrepancies in medical records did not prove fraud. The insurer had not produced cogent evidence to justify repudiation.
The health insurance sector grew 9 percent to cross Rs 1.2 lakh crore in premiums, with claim settlement ratios improving to 87.5 percent. But with 137,000 grievances logged last year, here is what policyholders must watch.
Over 70 percent of Indian consumers report premium hikes of 50 to 200 percent. With medical inflation at 14 percent and claim grievances jumping 41 percent, here is what every policyholder must know.
COVID-19 treatment can fall within health insurance coverage, but admissibility, waiting periods, testing, home care, preventive benefits and claim procedures depend on the policy. Here is what to verify before relying on coverage.
A Raipur consumer commission ordered Star Health to pay Rs 1.65 lakh after finding that the insurer had not produced medical evidence to substantiate its pre-existing-disease and lifestyle-based repudiation in this case.
The India Health Quotient 2026 found that only 12% of policyholders review their health insurance more than once a year. Regular review can reduce underinsurance and expectation gaps, but it is not the single explanation for claim rejection.
Know the current IRDAI health insurance claim settlement timelines: 1 hour for cashless pre-authorisation, 3 hours for discharge approval, and 15 days for non-cashless claims, plus what to do if your insurer delays.
A Parliamentary Standing Committee recommended increasing AB PM-JAY coverage from Rs 5 lakh to Rs 10 lakh per family. As of August 2026, the Government of India still describes the central scheme's cover as Rs 5 lakh per family per year.
The Maharashtra State Consumer Commission ordered Apollo Munich to pay Rs 20 lakh after finding, on the evidence before it, that a child's earlier speech delay was not shown to be a material pre-existing condition connected with the later cancer claim.
